Assessment of the Health Improvement of Obese Patients After Fecal Microbiota Transplantation (FMT)

Assessment of Improvement in Glycemic Control, Weight, and Insulin Sensitivity in Obese Patients After Fecal Microbiota Transplantation (FMT) Against the Background of Glucose-lowering Therapy

Search for mechanisms of the effect of fecal microbiota transplantation on patients with obesity

1. To select recipients of fecal samples according to eligibility criteria;
2. To perform fecal microbiota transplantation for patients with obesity;
3. To analyze the efficacy of fecal microbiota transplantation for patients with obesity within six months after therapy.

Inclusion Criteria:

• age of patients - from 18 to 75 years, both sexes;
• patients with obesity (body mass index ≥40
• patient's informed consent to perform fecal microbiota transplantation

Exclusion Criteria:

• presence of a concomitant chronic infectious disease or malignancy
• patients with a proven allergy to foods not excluded from the donor's diet
• absence of the patient for one or more intermediate stages of the examination.
• informed refusal to continue therapy